As filed with the Securities and Exchange
Commission on April 16, 2019. Registration No. 333-
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
S-3
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
CURO
GROUP HOLDINGS CORP.
(Exact name of registrant as specified
in its charter)
|
Delaware
|
6199
|
90-0934597
|
(State or other jurisdiction of incorporation
or organization)
|
(Primary Standard Industrial
Classification Code Number)
|
(I.R.S. Employer Identification Number)
|
3527 North Ridge Road
Wichita, Kansas 67205
(316) 722-3801
(Address, including Zip Code, and Telephone
Number, including Area Code, of Registrant’s Principal Executive Offices)
Vin Thomas
Chief Legal Officer
3527 North Ridge Road
Wichita, Kansas 67205
(316) 722-3801
(Name, Address, including Zip Code, and
Telephone Number, including Area Code, of Agent for Service)
Copies to:
Thomas
Mark
David Cosgrove
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, New York 10019
(212) 728-8000
Approximate date of commencement of proposed sale to the
public: From time to time after the effective date of this registration statement.
If the only securities being registered
on this form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.
¨
If any of the securities being
registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933,
other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.
x
If this form is filed to register
additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.
¨
If this form is a post-effective
amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering.
¨
If this form is a registration
statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with
the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.
¨
If this form is a post-effective
amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional
classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.
¨
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions
of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging
growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer
|
¨
|
Accelerated filer
|
x
|
|
|
|
|
|
|
Non-accelerated filer
|
¨
|
Smaller reporting company
|
¨
|
|
|
|
|
|
|
|
|
Emerging growth company
|
¨
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 7(a)(2)(B) of the Securities Act.
CALCULATION OF REGISTRATION FEE
|
Title of Each Class of Securities to Be Registered
|
|
Amount to Be
Registered (1)
|
|
|
Proposed Maximum
Offering Price per
Share (2)
|
|
|
Proposed Maximum
Aggregate Offering
Price (2)
|
|
|
Amount of
Registration
Fee
|
|
|
Common stock, par value $0.0001 per share (2)
|
|
|
32,542,555
|
(3)
|
|
$
|
11.17
|
|
|
$
|
363,500,339.35
|
|
|
$
|
44,056.24
|
|
|
|
(1)
|
Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares being registered hereunder include such indeterminate
number of shares of common stock as may be issuable with respect to the shares being registered hereunder as a result of stock
splits, stock dividends or similar transactions.
|
|
|
(2)
|
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities
Act of 1933, as amended. The proposed maximum offering price per share and proposed maximum aggregate offering price are based
on the average high and low prices of the Registrant’s common stock on April 12, 2019 as reported on the New York Stock Exchange.
|
|
|
(3)
|
Represents shares of our common stock that may be offered and sold from time to time by the selling stockholders identified
herein.
|
The registrant hereby amends this registration statement
on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment that
specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the Securities
and Exchange Commission, acting pursuant to Section 8(a), may determine.
The information in this
prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting
an offer to buy these securities in any state or other jurisdiction where the offer or sale is not permitted.
Subject to Completion,
dated April 16, 2019
PROSPECTUS
32,542,555
Shares
CURO
GROUP HOLDINGS CORP.
Common
Stock
From time-to-time,
with this prospectus, the selling stockholders identified in this prospectus may sell up to an aggregate of 32,542,555 shares of
our common stock. As described in the section entitled "Plan of Distribution," the selling stockholders may offer and
sell the shares of common stock on any stock exchange, market or trading facility on which the shares of common stock are traded
or in private transactions, at fixed or negotiated prices, directly to purchasers or through underwriters, broker-dealers or agents,
who may receive compensation in the form of discounts, concessions or commissions. We will not receive any of the proceeds from
the sale of the shares of our common stock by the selling stockholders. In certain circumstances, we will describe the specific
manner in which these shares will be offered in supplements to this prospectus, which may also supplement, update or amend information
contained in this prospectus. Before you invest, you should carefully read this prospectus and any prospectus supplement, together
with the documents we incorporate herein by reference.
Our common stock is
listed on the New York Stock Exchange under the symbol “CURO.” On April 15, 2019, the last reported sale price of our
common stock was $11.00 per share.
INVESTING IN
OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD CAREFULLY REVIEW THE RISKS AND UNCERTAINTIES REFERENCED UNDER THE
HEADING “RISK FACTORS” ON PAGE 7 OF THIS PROSPECTUS AS WELL AS THOSE IN ANY SIMILAR SECTION CONTAINED IN ANY
APPLICABLE PROSPECTUS SUPPLEMENT AND ANY RELATED FREE WRITING PROSPECTUS, AND IN THE OTHER DOCUMENTS THAT ARE INCORPORATED BY
REFERENCE INTO THIS PROSPECTUS OR ANY APPLICABLE PROSPECTUS SUPPLEMENT.
Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus is , 2019
TABLE OF CONTENTS
ABOUT THIS PROSPECTUS
This prospectus is part of a registration
statement that we filed with the Securities and Exchange Commission, or the SEC, using a “shelf” registration process.
Under this shelf registration process, the selling stockholders may, from time-to-time, offer and sell the offered securities in
one or more offerings or transactions.
In certain circumstances, we may provide
a prospectus supplement that will contain specific information about the terms of a particular offering. The prospectus supplement,
or information incorporated by reference in this prospectus or any prospectus supplement that is of a more recent date, may also
add, update or change information contained in this prospectus. To the extent that any statement that we make in a prospectus supplement
is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed modified or superseded
by those made in the prospectus supplement. You should read both this prospectus and any prospectus supplement together with the
additional information described below under the heading “Where You Can Find More Information.” We may also authorize
one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings.
You should rely only on the information
contained in or incorporated by reference in this prospectus, any accompanying prospectus supplement or in any related free writing
prospectus filed by us with the SEC. We have not authorized anyone to provide you with different information. If information is
given or representations are made, you may not rely on that information or representation as having been authorized by us. This
prospectus and any accompanying prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy
securities other than the securities described in such accompanying prospectus supplement or an offer to sell or the solicitation
of an offer to buy the securities in any circumstances in which such offer or solicitation is unlawful. You should assume that
the information appearing in this prospectus, any prospectus supplement, the documents incorporated by reference and any related
free writing prospectus is accurate only as of their respective dates, unless the information specifically indicates that another
date applies. Our business, financial condition, results of operations and prospects may have changed materially since those dates.
We are not making any representation to
you regarding the legality of an investment by you under any legal investment or similar laws or regulations. You should not consider
any information in this prospectus to be legal, business or tax advice. You should consult your own attorney, business advisor
and tax advisor for legal, business and tax advice regarding an investment in our securities.
Market data used throughout this prospectus
and the documents incorporated in this prospectus by reference, including information relating to our relative position in the
industries in which we conduct our business, is based on the good faith estimates of our management, which estimates are based
upon their review of internal surveys, independent industry publications and other publicly available information. Although we
believe these sources are reliable, we do not guarantee the accuracy or completeness of this information and we have not independently
verified this information. Although we are not aware of any misstatements regarding the market and industry data presented in this
prospectus, our estimates involve risks and uncertainties and are subject to change based on various factors, including those discussed
under the heading “Information Regarding Forward-Looking Statements” and “Risk Factors.”
We do not intend our use or display of
other companies’ tradenames, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us
by, any other company. Each trademark, tradename or service mark of any other company appearing in this prospectus is the property
of its respective holder.
We or one of our subsidiaries own or have
applied for ownership of the marks “CURO,” “CURO Financial Technologies Corp.,” “Speedy Cash®,”
“OPT+SM,” “Rapid Cash,” “Avio Credit,” “LendDirect” and “Wage Day Advance.”
All other trademarks, service marks and tradenames appearing in this prospectus are the property of their respective owners.
In this prospectus, when we refer to
|
|
•
|
“CURO,” we are referring to CURO Group Holdings Corp. and its subsidiaries
|
|
|
•
|
“CFTC,” we are referring to CURO Financial Technologies Corp., a wholly-owned subsidiary of CURO;
|
|
|
•
|
“FFL Holders,” we are referring to Friedman Fleischer & Lowe Capital Partners II,
L.P., FFL Executive Partners II, L.P. and FFL Parallel Fund II, L.P.; and
|
|
|
•
|
“Founder Holders,” we are referring to Doug Rippel, Chad Faulkner and Mike McKnight
and certain of their family trusts and affiliated entities.
|
Unless otherwise specified herein or the
context otherwise requires, all references to “$” in this prospectus refer to U.S. dollars and all references to “C$”
refer to Canadian dollars. The C$ is the functional currency of our Canadian operations.
For investors outside the United States:
neither we nor any of the selling stockholders have done anything that would permit possession or distribution of this prospectus
in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves
about and to observe any restrictions relating to the distribution of this prospectus outside of the United States.
WHERE YOU CAN FIND MORE INFORMATION
We file reports, proxy statements and other
information with the SEC under the Securities Exchange Act of 1934, or the Exchange Act. The SEC also maintains an Internet website
that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC. The
address of that website is
www.sec.gov.
We maintain a website at
www.curo.com
. You may access our reports,
proxy statements and other information free of charge at this website as soon as reasonably practicable after such material is
electronically filed with, or furnished to, the SEC. The information on such website is not incorporated by reference and is not
a part of this prospectus.
INCORPORATION OF CERTAIN INFORMATION
BY REFERENCE
The SEC allows us to “incorporate
by reference” the information that we file with them. This allows us to disclose important information to you by referring
to those filed documents. Any information referred to in this way is considered part of this prospectus, and any information that
we file with the SEC after the date of this prospectus will automatically update and supersede this information.
We are incorporating by reference the documents
listed below, and all documents that we file after the date of this prospectus with the SEC pursuant to Section 13(a), 13(c), 14
or 15(d) of the Exchange Act prior to the termination of the offering of securities covered by this prospectus:
|
|
•
|
Annual Report on Form 10
-
K
for the year ended December 31, 2018, filed with the SEC on March 18, 2019;
|
|
|
•
|
Current Reports on Form 8
-
K
filed with the SEC on January 31, 2019 (solely with respect to Item 8.01 thereof); February 1, 2019; February 11, 2019; February
25, 2019; March 1, 2019 (solely with respect to Item 2.01 and 9.01 thereof); March 19, 2019 and April 16, 2019;
|
|
|
•
|
Definitive Proxy Statement on Schedule 14A filed with the SEC o
n April 16, 2019;
and
|
|
|
•
|
The description of our common stock contained in our registration statement on Form 8-A as filed
with the SEC on December 4, 2017, including any amendments or reports filed for the purpose of updating the description.
|
Notwithstanding the foregoing, no information
is incorporated by reference in this prospectus where such information under applicable forms and regulations of the SEC is not
deemed to be “filed” under Section 18 of the Exchange Act or otherwise subject to the liabilities of that section,
unless we indicate in the report or filing containing such information that the information is to be considered “filed”
under the Exchange Act or is to be incorporated by reference in this prospectus.
We will furnish without charge to you,
on written or oral request, a copy of any or all of the documents incorporated by reference in this prospectus, including exhibits
to these documents specifically incorporated by reference therein. You should direct any requests for documents to our Chief Legal
Officer at: c/o CURO Group Holdings Corp., 3527 North Ridge Road, Wichita, Kansas 67205.
INFORMATION REGARDING FORWARD-LOOKING
STATEMENTS
This prospectus, any prospectus supplement
and the information incorporated by reference in this prospectus include forward-looking statements that involve risks and uncertainties.
These forward-looking statements include, without limitation, statements regarding our industry, business strategy, plans, goals
and expectations concerning our market position, product expansion, future operations, margins, profitability, future efficiencies,
capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion,
the words “may,” “believes,” “intends,” “seeks,” “anticipates,” “plans,”
“estimates,” “expects,” “should,” “assumes,” “continues,” “could,”
“will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking
statements in this prospectus and the information incorporated by reference in this prospectus.
Forward
-
looking
statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be
realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, our business
and operations involve numerous risks and uncertainties, many of which are beyond our control, which could result in our expectations
not being realized or otherwise materially affect our financial condition, results of operations and cash flows.
Our
forward
-
looking statements are not guarantees of future performance,
and actual events, results and outcomes may differ materially from our expectations suggested in any forward
-
looking
statements due to a variety of factors, including, among others, those set forth in the section entitled “Risk Factors.”
Although it is not possible to identify all of these factors, they include, among others, the following:
|
|
•
|
the identification of a material weakness in our internal control over financial reporting;
|
|
|
•
|
insufficiently providing for allowances for loan losses;
|
|
|
•
|
the adequacy of our allowance for loan losses, accrual for third-party loan losses and estimates of losses;
|
|
|
•
|
the higher levels of charge-offs we experience
due to the non
-
prime nature of our customers and the resulting
risk that we may not price our loan products appropriately in light of these charge-off levels;
|
|
|
•
|
risks associated with the failure of our proprietary credit and fraud scoring system to effectively
price the credit risk of our prospective or existing customers;
|
|
|
•
|
our failure to effectively forecast loss rates;
|
|
|
•
|
changes in demand for our products and services;
|
|
|
•
|
risks associated with effectively managing our growth;
|
|
|
•
|
our substantial indebtedness may expose us to material risks as we currently depend in large part
on debt financing to provide the cash needed to fund the loans we originate;
|
|
|
•
|
risks associated with our ability to refinance our substantial indebtedness;
|
|
|
•
|
changes in our financial condition or a potential disruption in the capital markets which could reduce available capital;
|
|
|
•
|
the lack of sufficient debt financing at acceptable prices or disruptions in the credit markets,
thereby reducing our access to credit and our ability to fund loans;
|
|
|
•
|
risks associated with a lack of sufficient debt financing made to our business on acceptable terms;
|
|
|
•
|
risks associated with disruption in the availability of our information systems;
|
|
|
•
|
adverse economic conditions which could cause demand for our loan products to decline or make it
more difficult for our customers to make payments on our loans and increase our default rates;
|
|
|
•
|
the possible impairment of goodwill;
|
|
|
•
|
the seasonality of our lending business;
|
|
|
•
|
the covenants in our debt agreements which may restrict our flexibility to operate our business;
|
|
|
•
|
implementation of new or changes in interpretation of existing accounting principles, financial reporting or tax law;
|
|
|
•
|
our ability to keep up with rapid changes in e
-
commerce,
the uses of the Internet and methods to access the same;
|
|
|
•
|
inability to affordably access third-party financing;
|
|
|
•
|
risks associated with our ability to protect our proprietary technology and analytics or keep up with that of our competitors;
|
|
|
•
|
risks associated with information provided by customers or third parties being inaccurate, and
causing us to misjudge a customer’s qualification to receive a loan;
|
|
|
•
|
risks associated with failure of third
parties who provide us products, services or support, including our ability to maintain relationships with banks and other third
-
party
electronic payment solutions providers;
|
|
|
•
|
our ability to maintain relationships with third
-
party
service providers to offer credit service organization loans in Texas;
|
|
|
•
|
the fragmentation of our industry and competition from various other sources providing similar
financial products, or other alternative sources of credit, to consumers;
|
|
|
•
|
risks related to operating outside of the United States;
|
|
|
•
|
risks related to potential inability to manage cash movements through the banking system or the
Automated Clearing House system;
|
|
|
•
|
risks associated with negative public perception of our products and services;
|
|
|
•
|
risks associated with the handling of
customer personal data and cyber
-
attacks that could result in liability
or harm to our reputation;
|
|
|
•
|
the sufficiency of indemnifications associated with assumed liabilities of acquired entities to
cover our exposures to litigation and settlement costs;
|
|
|
•
|
our ability to attract and retain qualified management and employees;
|
|
|
•
|
our ability to find suitable real estate to support future new store development;
|
|
|
•
|
the adverse impact of natural disasters and other business disruptions on our future revenue and financial condition;
|
|
|
•
|
our reliance on trademark protection to distinguish our products from the products of our competitors;
|
|
|
•
|
our ability to integrate acquisitions into our existing business operations;
|
|
|
•
|
risks associated with potential damages resulting from claims that our employees or we have wrongfully
used or disclosed alleged trade secrets of their former employers;
|
|
|
•
|
our ability to access preapproved marketing lists from credit bureaus or other developments impacting
our use of direct mail marketing;
|
|
|
•
|
the adverse impact of employee and third
-
party
theft and errors as well as liability resulting from crimes at our stores;
|
|
|
•
|
risks associated with judgments of management required in preparation of our financial statements
and certain tax positions;
|
|
|
•
|
risks associated with exiting the U.K. market and thereby decreasing the size of our total addressable market;
|
|
|
•
|
the CFPB examination authority over our U.S. consumer lending business;
|
|
|
•
|
the CFPB Rule on payday, vehicle title, and certain high
-
cost
installment loans;
|
|
|
•
|
the extent to which federal, state, local and foreign governmental regulation of consumer lending
and related financial products and services limits or prohibits the operation of our business;
|
|
|
•
|
our failure to comply with applicable laws and regulations, and resulting fines, penalties or other sanctions;
|
|
|
•
|
the impact of the complex regulatory environment in which we operate, which increases our costs
of compliance and the risk that we may fail to comply;
|
|
|
•
|
current and future litigation and regulatory proceedings against us;
|
|
|
•
|
the impact of existing, new or proposed local and state regulation of our industry;
|
|
|
•
|
risks associated with future judicial decisions or new legislation which could potentially render
our arbitration agreements unenforceable;
|
|
|
•
|
the adverse impact of material modifications of U.S. laws and regulations and existing trade agreements
by the U.S. presidential administration on our business, financial condition, and results of operations;
|
|
|
•
|
the risk that our interpretation and application of laws and regulations related to consumer lending
activities differs from the interpretations applied by federal, state, local and foreign regulatory bodies;
|
|
|
•
|
the effect of judicial decisions, agency rulemaking, or amendments to law on the legality or enforceability
of our agreements; and
|
|
|
•
|
the impact of any litigation or investigation on us, including the pending securities claims and
inquiries from governmental agencies related to our public disclosures surrounding our efforts to transition our Canadian inventory
of products from single-pay loans to open-end loans, and the sufficiency of our insurance, including our directors’ and officers’
policies.
|
Any
one of these factors or a combination of these factors could materially affect our future results of operations and could influence
whether any forward
-
looking statements ultimately prove to be accurate.
Our forward
-
looking statements speak only as of the date hereof
and are not guarantees of future performance. Actual results and future performance may differ materially from those suggested
in any forward
-
looking statements.
We and the selling stockholders undertake
no obligation to update these statements unless we are required to do so under applicable laws.
ABOUT CURO
We
are a growth
-
oriented, technology
-
enabled,
highly
-
diversified, multi
-
channel
and multi
-
product consumer finance company serving a wide range
of underbanked consumers in the United States, or U.S., Canada and, through February 25, 2019, the United Kingdom, or U.K., and
are a market leader in our industry based on revenues. We believe that we have the only true omni
-
channel
customer acquisition, onboarding and servicing platform that is integrated across store, online, mobile and contact center touchpoints.
Our IT platform, which we refer to as the “Curo Platform,” seamlessly integrates customer acquisition loan underwriting,
scoring, servicing, collections, regulatory compliance and reporting activities into a single, centralized system. We use advanced
risk analytics powered by proprietary algorithms and over 15 years of loan performance data to efficiently and effectively score
our customers’ loan applications. From January 1, 2010 through December 31, 2018, we extended over $17.1 billion in total
credit across approximately 43.8 million total loans.
We operate in the U.S. under two principal
brands, “Speedy Cash” and “Rapid Cash,” as well as under the “Avio Credit” brand, which is
currently available in 11 states. We operate in Canada under two principal brands, “Cash Money” and “LendDirect,”
which offers Installment loans online and at certain stores.
On February 25, 2019, in accordance with
the provisions of the U.K. Insolvency Act 1986 and as approved by the boards of directors of the Company’s U.K. subsidiaries,
Curo Transatlantic Limited and SRC Transatlantic Limited (collectively with Curo Transatlantic Limited, “the U.K. Subsidiaries”),
insolvency practitioners from KPMG were appointed as administrators (“Administrators”) in respect of both of the U.K.
Subsidiaries. The effect of the U.K. Subsidiaries’ entry into administration was to place the management, affairs, business
and property of the U.K. Subsidiaries under the direct control of the Administrators. Accordingly, we deconsolidated the U.K. Subsidiaries
as of February 25, 2019 and will present the U.K. Subsidiaries as Discontinued Operations beginning with our Quarterly Report on
Form 10-Q for the quarter ended March 31, 2019.
As of December 31, 2018, our store network
consisted of 413 locations across 14 U.S. states and seven Canadian provinces and we offered our online services in 27 U.S. states,
five Canadian provinces and the U.K.
We
offer a broad range of consumer finance products, including Unsecured Installment loans, Secured Installment loans, Open
-
End
loans and Single
-
Pay loans. We have tailored our products to fit
our customers’ particular needs as they access and build credit. We believe that our product suite allows us to serve a broader
group of potential borrowers than most of our competitors. The flexibility of our products, particularly our Installment and Open
-
End
products, allows us to continue serving customers as their credit needs evolve and mature. Our broad product suite creates a diversified
revenue stream and our omni
-
channel platform seamlessly delivers
our products across all contact points—we refer to it as “Call, Click or Come In.” We believe these complementary
channels drive brand awareness, increase approval rates, lower our customer acquisition costs and improve customer satisfaction
levels and customer retention. We serve the large and growing market of individuals who have limited access to traditional sources
of consumer credit and financial services.
CURO
was founded in 1997 in California and, over 20 years of operations, expanded across the U.S. and Canada, and through February 25,
2019 the U.K. CFTC (then known as Speedy Cash Holdings Corp.) was incorporated in Delaware in July 2008. In September 2008, our
founders sold or contributed all of the outstanding equity of the various operating entities that comprised the CURO business to
a wholly
-
owned subsidiary of CFTC in connection with an investment
in CFTC by Friedman Fleischer & Lowe Capital Partners II, L.P. and its affiliated funds, or FFL Partners. CURO Group Holdings
Corp. (then known as Speedy Group Holdings Corp.) was incorporated in Delaware in February 2013 as the parent company of CFTC.
On May 11, 2016, we changed the name of Speedy Group Holdings Corp. to CURO Group Holdings Corp.
Our directors (including the Founder Holders),
executive officers and the FFL Holders, together beneficially own approximately 65% of our outstanding common stock as of April
1, 2019.
Our principal business office is located
at 3527 North Ridge Road, Wichita, Kansas 67205. Our website address is
www.curo.com
. We do not incorporate the
information contained on, or accessible through, our corporate website into this prospectus, and you should not consider it to
be part of this prospectus.
RISK FACTORS
Our operations and financial results are
subject to various risks and uncertainties that could adversely affect our business, results of operations, financial condition
and future results. Please see the risk factors under the heading “Risk Factors” in our most recently filed Annual
Report on Form 10-K, as revised or supplemented by our Quarterly Reports on Form 10-Q filed with the SEC since the filing of our
most recent Annual Report on Form 10-K, all of which are incorporated by reference in this prospectus. Before making an investment
decision, you should carefully consider these risks as well as other information we include or incorporate by reference in this
prospectus and any prospectus supplement. The risks and uncertainties we have described are not the only ones facing our company.
Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business
operations.
USE OF PROCEEDS
We will not receive any proceeds from the
sale of common stock by the selling stockholders. All proceeds from the sale of the shares of common stock will be for the accounts
of the selling stockholders. See “Selling Stockholders” and “Plan of Distribution.”
DIVIDEND POLICY
We do not currently intend to pay cash
dividends on our common stock and do not anticipate paying any dividends on our common stock in the foreseeable future. Any future
determinations relating to our dividend policies will be made at the discretion of our Board of Directors and will depend on conditions
then existing, including our financial condition, results of operations, contractual restrictions, capital requirements, business
prospects and other factors our Board of Directors may deem relevant.
DESCRIPTION OF SECURITIES
The following description of our capital
stock and certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws are summaries.
You should read these summaries in conjunction with our amended and restated certificate of incorporation and amended and restated
bylaws, copies of which are filed as exhibits to the registration statement of which this prospectus is a part.
Our authorized capital stock consists of
25,000,000 shares of preferred stock, par value $0.001 per share, and 225,000,000 shares of common stock, par value $0.001 per
share. As of December 31, 2018, there were 46,412,231 shares of our common stock outstanding.
Common Stock
Voting rights
Holders of shares of our common stock are
entitled to one vote for each share of common stock held on all matters submitted to a vote of the stockholders. Generally, holders
of shares of our common stock vote together as a single class on all matters (including the election of directors) submitted to
a vote of the stockholders, unless otherwise required by law or with respect to the matters described in the immediately following
paragraph. Generally, all matters to be voted on by the stockholders must be approved by a majority of the votes cast by all shares
of common stock present in person or represented by proxy, voting together as a single class.
Notwithstanding the foregoing paragraph,
amendments to our amended and restated certificate of incorporation, including as a result of a statutory merger, that would alter
or change the powers, preferences or the common stock so as to affect them adversely must also be approved by a majority of the
votes entitled to be cast by the holders of the shares affected by the amendment, voting as a separate class. Under our amended
and restated certificate of incorporation, we may not increase or decrease the authorized number of shares of common stock without
the affirmative vote of the holders of a majority of the voting power of the outstanding shares of our capital stock entitled to
vote, voting together as a single class.
Dividend rights
Subject to preferences that may apply to
any shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive dividends out of
funds legally available if our Board of Directors, in its discretion, determines to issue dividends and then only at the times
and in the amounts that our Board of Directors may determine. See “Dividend Policy” above for additional information.
No preemptive
or similar rights
Our common stock is not entitled to preemptive
rights and is not subject to redemption or sinking fund provisions.
Right to receive
liquidation distributions
Upon
our liquidation, dissolution or winding
-
up, the assets legally
available for distribution to our stockholders would be distributable ratably among the holders of shares of our common stock and
any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities
and the preferential rights of, and the payment of liquidation preferences on, if any, any outstanding shares of preferred stock.
All
of the shares of our common stock currently issued and all shares of our common stock are fully paid and non
-
assessable.
Preferred Stock
Under the terms of our amended and restated
certificate of incorporation, our Board of Directors is authorized to issue shares of preferred stock in one or more series without
stockholder approval. Our Board of Directors has the discretion to determine the rights, preferences, privileges and restrictions,
including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series
of preferred stock.
The purpose of authorizing our Board of
Directors to issue preferred stock and determine its rights and preferences was to eliminate delays associated with a stockholder
vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible future acquisitions
and other corporate purposes, will affect, and may adversely affect, the rights of holders of common stock. It is not possible
to state the actual effect of the issuance of any shares of preferred stock on the rights of holders of common stock until the
Board of Directors determines the specific rights attached to that preferred stock. The effects of issuing preferred stock could
include one or more of the following:
|
|
•
|
restricting dividends on the common stock;
|
|
|
•
|
diluting the voting power of the common stock;
|
|
|
•
|
impairing the liquidation rights of the common stock; or
|
|
|
•
|
delaying or preventing changes in control or management of us.
|
We have no preferred stock outstanding
and no present plans to issue any shares of preferred stock.
Anti
-
Takeover
Effects of Delaware Law and Our Certificate of Incorporation and Bylaws
The provisions of Delaware law and our
amended and restated certificate of incorporation and amended and restated bylaws may have the effect of delaying, deferring or
discouraging another person from acquiring control of the Company. These provisions, which are summarized below, may have the effect
of hampering takeover bids. They are also designed, in part, to encourage persons seeking to acquire control of us to negotiate
first with our Board of Directors. We believe that the benefits of increased protection of our potential ability to negotiate with
an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us, because negotiation
of these proposals could result in an improvement of their terms.
Delaware
Anti
-
Takeover Statute
Section 203 of the General Corporation
Law of the State of Delaware prohibits a publicly held Delaware corporation from engaging, under certain circumstances, in a business
combination with an interested stockholder for a period of three years following the date the person became an interested stockholder
unless:
|
|
•
|
prior to the date of the transaction, the Board of Directors of the corporation approved either
the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;
|
|
|
•
|
upon completion of the transaction that resulted in the stockholder becoming an interested stockholder,
the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced,
calculated as provided under Section 203; or
|
|
|
•
|
at or subsequent to the date of the transaction,
the business combination is approved by the Board of Directors of the corporation and authorized at an annual or special meeting
of the stockholders, and not by written consent, by the affirmative vote of at least two
-
thirds
of the outstanding voting stock which is not owned by the interested stockholder.
|
Generally, a business combination includes
a merger, asset or stock sale or other transaction resulting in a financial benefit to the interested stockholder. An interested
stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of
interested stockholder status, did own, 15% or more of a corporation’s outstanding voting stock.
The provisions of Delaware law and the
provisions of our amended and restated certificate of incorporation and amended and restated bylaws, could have the effect of discouraging
others from attempting hostile takeovers and, as a consequence, they might also inhibit temporary fluctuations in the market price
of our common stock that often result from actual or rumored hostile takeover attempts. These provisions might also have the effect
of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions
that stockholders might otherwise deem to be in their best interests.
Classified Board
Our Board of Directors
is classified into three classes of directors, and directors may be removed from office only for cause. The existence of a classified
board of directors could delay a successful tender offeror from obtaining majority control of our Board of Directors, and the prospect
of that delay might deter a potential offeror.
Undesignated
Preferred Stock
As discussed above
in “—Preferred Stock,” our Board of Directors has the ability to issue preferred stock with voting or other rights
or preferences that could impede the success of any attempt to change control of us. These and other provisions may have the effect
of deterring hostile takeovers or delaying changes in control or management of us.
No Cumulative
Voting
Under Delaware law,
the right to vote cumulatively does not exist unless the certificate of incorporation specifically authorizes cumulative voting.
Our amended and restated certificate of incorporation does not authorize cumulative voting. Therefore, stockholders holding a majority
in voting power of the shares of our stock entitled to vote generally in the election of directors are able to elect all our directors.
Action by Written
Consent
Our amended and restated certificate of
incorporation provides that actions by our stockholders may not be taken by written consent. Actions to be taken by our stockholders
may be taken only at an annual or special meeting of our stockholders.
Ability of Stockholders to Call a
Special Meeting
Our amended and restated bylaws provide
that special meetings of the stockholders may be called only by the chairperson of the Board of Directors, our Chief Executive
Officer or a majority of our Board of Directors. Stockholders may not otherwise call a special meeting, which may delay the ability
of our stockholders to force consideration of a proposal.
Requirements
for Advance Notification of Stockholder Nominations and Proposals
Our amended and restated bylaws contain
advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other
than nominations made by or at the direction of our Board of Directors or a committee of our Board of Directors. These provisions
may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed. These
provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s
own slate of directors or otherwise attempting to obtain control of us.
Amendment of
Charter Provisions
The amendment of the above provisions of
our amended and restated certificate of incorporation and amended and restated bylaws requires approval by holders of at least
a majority of our outstanding capital stock entitled to vote generally in the election of directors. In addition, amendments to
our amended and restated certificate of incorporation, including as a result of a statutory merger, that would alter or change
the powers, preferences or rights of the common stock so as to affect them adversely must also be approved by a majority of the
votes entitled to be cast by the holders of the shares affected by the amendment, voting as a separate class. Under our amended
and restated certificate of incorporation, we may not increase or decrease the authorized number of shares of common stock without
the affirmative vote of the holders of a majority of the voting power of the outstanding shares of our capital stock entitled to
vote, voting together as a single class.
Choice of Forum
Our amended and restated certificate of
incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for: (i) any derivative action
or proceeding brought on our behalf; (ii) any action asserting a breach of fiduciary duty; (iii) any action asserting a claim against
us arising pursuant to the General Corporation Law of the State of Delaware, our certificate of incorporation or bylaws; and (iv)
any action asserting a claim against us that is governed by the internal affairs doctrine.
Corporate Opportunity
Our amended and restated certificate of
incorporation provides that we renounce any interest or expectancy in, or in being offered an opportunity to participate in, any
business opportunity that may from time-to-time be presented to the FFL Holders or any of their respective officers, directors,
agents, stockholders, members, managers, partners, affiliates and subsidiaries (other than us and our subsidiaries) and that may
be a business opportunity for the FFL Holders, even if the opportunity is one that we might reasonably have pursued or had the
ability or desire to pursue if granted the opportunity to do so. No such person is liable to us for breach of any fiduciary or
other duty, as a director or officer or otherwise, to the fullest extent permitted by law, by reason of the fact that such person
pursues or acquires any such business opportunity, directs any such business opportunity to another person or fails to present
any such business opportunity, or information regarding any such business opportunity, to us. Neither the FFL Holders nor any of
their respective representatives has any duty to refrain from engaging directly or indirectly in the same or similar business activities
or lines of business as us or any of our subsidiaries.
Limitation on Director and Officer Liability and Indemnification
Our amended and restated certificate of
incorporation contains provisions that limit the liability of our directors and officers for monetary damages to the fullest extent
permitted by Delaware law. Consequently, our directors and officers are not personally liable to us or our stockholders for monetary
damages for any breach of fiduciary duties as directors or officers, except liability for:
|
|
•
|
any breach of the duty of loyalty to us or our stockholders;
|
|
|
•
|
any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
|
|
|
•
|
any unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in
Section 174 of the General Corporation Law of the State of Delaware; or
|
|
|
•
|
any transaction from which an improper personal benefit is derived.
|
Our amended and restated certificate of
incorporation and amended and restated bylaws provide that we are required to indemnify our directors and officers, in each case
to the fullest extent permitted by Delaware law. Our amended and restated bylaws also provide that we are obligated to advance
expenses incurred by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure
insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that
capacity regardless of whether we would otherwise be permitted to indemnify him or her under the provisions of Delaware law.
We have entered into agreements to indemnify
our directors and executive officers. With specified exceptions, these agreements provide for indemnification for related expenses
including, among other things, attorneys’ fees, judgments, fines and settlement amounts incurred by any of these individuals
in any action or proceeding. We believe these bylaw provisions and indemnification agreements are necessary to attract and retain
qualified persons as directors and officers. We also maintain directors’ and officers’ liability insurance.
The limitation of liability and indemnification
provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders
from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood
of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and other stockholders.
Further, a stockholder’s investment may be adversely affected to the extent that we pay the costs of settlement and damage
awards against directors and officers as required by these indemnification provisions. At present, there is no pending litigation
or proceeding involving any of our directors, officers or employees for which indemnification is sought, and we are not aware of
any threatened litigation that may result in claims for indemnification.
Registration Rights
The Amended and Restated Investor Rights
Agreement, dated December 11, 2017 and as further amended on May 14, 2018 and April 16, 2019 (the “Amended and Restated Investor
Rights Agreement”), provides certain holders of our common stock, including the Founders Holders and Freidman Fleisher &
Lowe Capital Partners II, L.P. (and its affiliated funds, the “FFL Funds”), subject to certain conditions, certain
registration rights. In connection with this prospectus, the parties to the Amended and Restated Investor Rights Agreement have
entered into an amendment thereto, in order to provide for certain waivers of the advance notice provisions of registration rights
under the Amended and Restated Investor Rights Agreement and the treatment of the offer and sale of shares of our common stock
by the selling stockholders contemplated by this prospectus as a demand registration thereunder.
Market Listing
Our common stock is listed on the NYSE
under the symbol “CURO.”
Transfer Agent and Registrar
The
transfer agent and registrar for our common stock is American Stock Transfer & Trust Company, LLC. The transfer agent’s
address is 6201 15th Avenue, Brooklyn, New York 11219 and telephone number is (800) 937
-
5449.
SELLING STOCKHOLDERS
The following table sets forth the number
of shares of common stock beneficially owned by the selling stockholders prior to this offering, the percentage of common stock
beneficially owned by the selling stockholders prior to this offering, the number of shares of common stock offered for sale by
the selling stockholders in this offering, the number of shares of common stock to be beneficially owned by the selling stockholders
after completion of this offering and the percentage of common stock to be beneficially owned by the selling stockholders after
the completion of this offering. We have prepared the table based on information given to us by, or on behalf of, the selling stockholders
on or before April 12, 2019. The percentage of common stock beneficially owned by the selling stockholders set forth in the table
is based on 46,431,289 shares of our common stock issued and outstanding as of April 12, 2019, the number of shares of common stock
offered hereby and registered by the registration statement of which this prospectus is a part and the number of shares of common
stock to be owned by each selling stockholder after the maximum number of shares being offered hereby are sold, which assumes that
all shares of common stock covered by this prospectus will be sold by the selling stockholders and that no additional shares of
common stock of the Company are subsequently bought or sold by the selling stockholders. However, because the selling stockholders
may offer from time-to-time all, some or none of their shares of common stock under this prospectus, or in another permitted manner,
no assurances can be given as to the actual number of shares of common stock that will be sold by the selling stockholders or that
will be held by the selling stockholders after completion of the sales. In addition, we do not know how long the selling stockholders
will hold their shares before selling them.
Unless otherwise noted below, each stockholder’s
address is c/o CURO Group Holdings Corp., 3527 North Ridge Road, Wichita, Kansas 67205.
Except as set forth in the footnotes below,
none of the selling stockholders has served as our officer or director within the last three years, nor has any selling stockholder
had a material relationship with us. No selling stockholder is either a broker-dealer or an affiliate of a broker-dealer. None
of the selling stockholders had any agreement or understanding, directly or indirectly, to distribute any of the shares being registered
at the time of purchase.
|
|
|
Shares Beneficially
Owned
Prior to Offering
|
|
|
Number of
Shares Covered
by this
Registration
|
|
|
Shares Beneficially
Owned After the
Covered Shares are
Sold
|
|
|
Name of Selling Stockholder
|
|
Number
|
|
|
Percent
|
|
|
Statement
|
|
|
Number
|
|
|
Percent
|
|
|
FFL Holders
(1)(2)
|
|
|
9,162,392
|
|
|
|
19.73
|
|
|
|
9,162,392
|
|
|
|
0
|
|
|
|
*
|
|
|
Rippel Holdings, LLC
(2)(3)(6)
|
|
|
6,883,524
|
|
|
|
14.83
|
|
|
|
6,883,524
|
|
|
|
0
|
|
|
|
*
|
|
|
McKnight Holdings, LLC
(2)(4)(6)
|
|
|
6,383,524
|
|
|
|
13.75
|
|
|
|
6,383,524
|
|
|
|
0
|
|
|
|
*
|
|
|
Exempt Family Trust c/u Leah M. Faulkner 2017 Dynasty Trust
(2)(5)(6)
|
|
|
3,191,779
|
|
|
|
6.87
|
|
|
|
3,191,779
|
|
|
|
0
|
|
|
|
*
|
|
|
Exempt Family Trust c/u Chadwick H. Faulkner 2017 Dynasty Trust
(2)(5)(6)
|
|
|
3,191,743
|
|
|
|
6.87
|
|
|
|
3,191,743
|
|
|
|
|
|
|
|
|
|
|
J.P. Genova Family Trust
(2)
|
|
|
1,894,752
|
|
|
|
4.08
|
|
|
|
1,894,752
|
|
|
|
0
|
|
|
|
*
|
|
|
Matthew Miller
(2)
|
|
|
1,272,869
|
|
|
|
2.74
|
|
|
|
1,272,869
|
|
|
|
0
|
|
|
|
*
|
|
|
James Ackerman
(2)
|
|
|
287,972
|
|
|
|
*
|
|
|
|
287,972
|
|
|
|
0
|
|
|
|
*
|
|
|
Nick Adams
(2)
|
|
|
274,000
|
|
|
|
*
|
|
|
|
274,000
|
|
|
|
0
|
|
|
|
*
|
|
|
* Represents beneficial ownership of less than 1%.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Amounts shown reflect 8,671,443 shares of common stock held by Friedman Fleischer & Lowe Capital
Partners II, L.P., 166,371 shares of common stock held by FFL Executive Partners II, L.P. and 324,578 shares of common stock held
by FFL Parallel Fund II, L.P. The FFL Holders are controlled by Friedman Fleischer & Lowe GP II, LP, their general partner,
which may be deemed a beneficial owner of the shares of common stock, with shared voting and dispositive power over such shares.
The address of the FFL Holders is c/o FFL Partners, LLC, One Maritime Plaza, Suite 2200, San Francisco, California 94111.
|
|
|
(2)
|
In connection with the completion of our initial public offering, we entered into the Amended and
Restated Investor Rights Agreement with certain of our existing stockholders, including the FFL Holders and Founder Holders. Pursuant
to the Amended and Restated Investors Rights Agreement, we have agreed to register the sale of shares of our common stock held
by the stockholders party thereto under certain circumstances. Our directors Chris Masto and Karen Winterhof are affiliates of
the FFL Holders.
|
|
|
(3)
|
Mr. Rippel is the sole member of Rippel Holdings, LLC. Mr. Rippel is a member of our Board of Directors.
|
|
|
(4)
|
Mr. McKnight is the sole member of McKnight Holdings, LLC. Mr. McKnight is a member of our
Board of Directors.
|
|
|
(5)
|
Mr. Faulkner is the adviser of the Exempt Family Trust c/u Leah M. Faulkner 2017 Dynasty Trust
and the Exempt Family Trust c/u Chadwick H. Faulkner 2017 Dynasty Trust (the “Faulkner Trusts”). Mr. Faulkner
disclaims beneficial ownership of the shares held by the Faulkner Trusts except to the extent of his pecuniary interest therein.
Mr. Faulkner is a member of our Board of Directors.
|
|
|
(6)
|
We lease certain facilities from the Founder Holders
(either directly or through entities in which they have a material interest). For more information, please see "Certain Relationships
and Related Party Transactions" in our Definitive Proxy Statement on Schedule 14A filed with the SEC on April 16, 2019.
|
PLAN OF DISTRIBUTION
The selling stockholders (including any selling stockholder’s
transferees, assignees or other successors-in-interest) may sell the securities offered under this prospectus in any one or more
of the following ways from time-to-time:
|
|
•
|
to or through underwriters;
|
|
|
•
|
through brokers or dealers;
|
|
|
•
|
through a block trade in which the broker or dealer engaged to handle the block trade will attempt to sell the shares as agent,
but may position and resell a portion of the block as principal to facilitate the transaction;
|
|
|
•
|
directly to one or more purchasers, including through a specific bidding, auction or other process;
|
|
|
•
|
through a combination of any of these methods of sale; or
|
|
|
•
|
any other method permitted by applicable law.
|
The securities may be sold in one or more transactions at:
|
|
•
|
prevailing market prices at the time of sale;
|
|
|
•
|
prices related to the prevailing market prices;
|
|
|
•
|
varying prices determined at the time of sale; or
|
These sales may be effected in transactions:
|
|
•
|
on any national securities exchange or quotation service on which our common stock may be listed or quoted at the time of sale,
including the New York Stock Exchange;
|
|
|
•
|
in the over-the-counter market;
|
|
|
•
|
otherwise than on such exchanges or services or in the over-the-counter market;
|
|
|
•
|
through the writing of options, whether the options are listed on an options exchange or otherwise (including the issuance
by the selling stockholders of derivative securities);
|
|
|
•
|
through the settlement of short sales; or
|
|
|
•
|
through a combination of the foregoing.
|
These transactions may include block transactions or crosses.
Crosses are transactions in which the same broker acts as agent on both sides of the trade.
If required by applicable law, we will
describe in a prospectus supplement the particular terms of the offering of the securities, including the following:
|
|
•
|
the names of any agents, underwriters, brokers or dealers;
|
|
|
•
|
the purchase price of the securities and the net proceeds from the sale;
|
|
|
•
|
any underwriting discounts and other items constituting underwriters’ compensation;
|
|
|
•
|
any public offering price and any discounts or concessions allowed or reallowed or paid to dealers;
|
|
|
•
|
any securities exchanges on which the shares of common stock may be listed; and
|
|
|
•
|
any other information we think is material.
|
In addition, any selling stockholder may
sell securities covered by this prospectus in private transactions or under Rule 144 of the Securities Act of 1933 rather than
pursuant to this prospectus.
The selling stockholders may sell securities
from time-to-time through agents. We will name any agent involved in the offer or sale of such securities and will list commissions
payable to these agents in a prospectus supplement, if required. These agents will be acting on a best efforts basis to solicit
purchases for the period of their appointment, unless we state otherwise in any required prospectus supplement.
In connection with the sale of securities
covered by this prospectus, broker-dealers may receive commissions or other compensation from us or the selling stockholders in
the form of commissions, discounts or concessions. Broker-dealers may also receive compensation from purchasers of the securities
for whom they act as agents or to whom they sell as principals or both. Compensation as to a particular broker-dealer may be in
excess of customary commissions or in amounts to be negotiated. In connection with any underwritten offering, underwriters may
receive compensation in the form of discounts, concessions or commissions from us, a selling stockholder or from purchasers of
the securities for whom they act as agents. Underwriters may sell the securities to or through dealers, and such dealers may receive
compensation in the form of discounts, concessions or commissions from the underwriters and/or commissions from the purchasers
for whom they may act as agents. Any underwriters, broker-dealers, agents or other persons acting on our behalf or on behalf of
any selling stockholders that participate in a distribution of securities may be deemed to be “underwriters” within
the meaning of the Securities Act, and any profit on the sale of the securities by them and any discounts, commissions or concessions
received by any of those underwriters, broker-dealers, agents or other persons may be deemed to be underwriting discounts and commissions
under the Securities Act.
The aggregate amount of compensation in
the form of underwriting discounts, concessions or fees and any profit on the resale of shares by the selling stockholders that
may be deemed to be underwriting compensation pursuant to Financial Industry Regulatory, Inc. Rule 5110 will not exceed 8% of the
gross proceeds of the offering to the selling stockholders.
In connection with the distribution of
the common stock covered by this prospectus or otherwise, and subject to our insider trading policy to the extent applicable at
such time to a selling stockholder, the selling stockholders may enter into hedging transactions with broker-dealers or other financial
institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of
our securities in the course of hedging the positions they assume with a selling stockholder. A selling stockholder may also sell
shares of common stock short and deliver the shares of common stock offered by this prospectus to close out short positions. A
selling stockholder may also enter into options or other transactions with broker-dealers or other financial institutions that
require the delivery to such broker-dealer or other financial institution of shares of common stock offered by this prospectus,
which shares such broker-dealer or other financial institution may resell pursuant to this prospectus, as supplemented or amended
to reflect such transaction. A selling stockholder may also from time to time pledge our securities pursuant to the margin provisions
of customer agreements with a broker or other agreements with lenders. Upon a default, the broker or lender may offer and sell
such pledged shares from time to time pursuant to this prospectus, as supplemented or amended to reflect such transaction.
Underwriters, agents, brokers or dealers
may be entitled, pursuant to relevant agreements entered into with us, to indemnification by us or a selling stockholder against
certain civil liabilities, including liabilities under the Securities Act that may arise from any untrue statement or alleged untrue
statement of a material fact, or any omission or alleged omission to state a material fact in this prospectus, any supplement or
amendment hereto, or in the registration statement of which this prospectus forms a part, or to contribution with respect to payments
which the underwriters, agents, brokers or dealers may be required to make.
The selling stockholders and any other
person participating in such distribution will be subject to the applicable provisions of the Exchange Act and the rules and regulations
thereunder, including, without limitation, Regulation M, which may limit the timing of purchases and sales of any of the shares
by the selling stockholders and any other participating person. Regulation M may also restrict the ability of any person engaged
in the distribution of the shares to engage in market-making activities with respect to the shares. All of the foregoing may affect
the marketability of the shares and the ability of any person or entity to engage in market-making activities with respect to the
shares.
There can be no assurance that any selling
stockholder will sell any or all of the securities registered pursuant to the registration statement of which this prospectus is
a part.
LEGAL MATTERS
Unless otherwise specified in a prospectus
supplement accompanying this prospectus, Willkie Farr & Gallagher LLP, New York, New York will pass upon the validity of the
shares of common stock offered hereby. If any legal matters relating to offerings made in connection with this prospectus are passed
upon by other counsel for underwriters, dealers or agents, such counsel will be named in the prospectus supplement relating to
any such offering.
EXPERTS
The consolidated financial statements of
CURO Group Holdings Corp. appearing in CURO Group Holdings Corp.’s Annual Report on Form 10-K for the year ended December
31, 2018 including schedules appearing therein, and the effectiveness of CURO Group Holdings Corp.’s internal control over
financial reporting as of December 31, 2018, have been audited by Grant Thornton LLP, independent registered public accounting
firm, as set forth in their reports thereon included therein, and incorporated herein by reference. Such financial statements are,
and audited financial statements to be included in subsequently filed documents will be, incorporated herein in reliance upon the
reports of Grant Thornton LLP pertaining to such financial statements and the effectiveness of our internal control over financial
reporting as of the respective dates (to the extent covered by consents filed with the SEC) given on the authority of such firm
as experts in accounting and auditing.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution
The following table sets forth the estimated
costs and expenses, other than underwriting discounts and commissions, payable by us in connection with the sale of the securities
being registered. Pursuant to the Amended and Restated Investor Rights Agreement, we have agreed to pay these costs and expenses
on behalf of the selling stockholders. All amounts shown are estimates, except the SEC registration fee.
|
|
|
Amount to be Paid
|
|
|
SEC registration fee
|
|
$
|
44,056.24
|
|
|
Legal fees and expenses
|
|
|
400,000
|
*
|
|
Accounting fees and expenses
|
|
|
150,000
|
*
|
|
Printing Expenses
|
|
|
50,000
|
*
|
|
Miscellaneous
|
|
|
20,000
|
*
|
|
TOTAL
|
|
|
664,056.24
|
*
|
|
|
*
|
The amounts shown are estimates of expenses payable by
us in connection with the filing of this registrations statement and one underwritten offering of securities hereunder, but do
not limit the amount of securities that may be offered.
|
Item 15. Indemnification of Directors and Officers
Section 145 of the General Corporation
Law of the State of Delaware authorizes a court to award, or a corporation’s board of directors to grant, indemnity to officers
and directors under certain circumstances and subject to certain limitations. The terms of Section 145 of the General Corporation
Law of the State of Delaware are sufficiently broad to permit indemnification under certain circumstances for liabilities, including
reimbursement of expenses incurred, arising under the Securities Act of 1933, as amended.
As permitted by Section 102(b)(7) of the
General Corporation Law of the State of Delaware, the registrant’s amended and restated certificate of incorporation includes
provisions that eliminate the personal liability of its directors for monetary damages for any breach of fiduciary duties as a
director, except liability for the following:
|
|
•
|
any breach of the director’s duty of loyalty to the registrant or its stockholders;
|
|
|
•
|
acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law;
|
|
|
•
|
under Section 174 of the General Corporation Law of the State of Delaware (regarding unlawful dividends
and stock purchases); or
|
|
|
•
|
any transaction from which the director derived an improper personal benefit.
|
To the extent Section 102(b)(7) is interpreted,
or the General Corporation Law of the State of Delaware is amended, to allow similar protections for officers of a corporation,
such provisions of the registrant’s amended and restated certificate of incorporation shall also extend to those persons.
In addition, as permitted by Section 145
of the General Corporation Law of the State of Delaware, the amended and restated bylaws of the registrant provide that:
|
|
•
|
The registrant shall indemnify its directors and officers for serving the registrant in those capacities
or for serving other business enterprises at the registrant’s request, to the fullest extent permitted by Delaware law. Delaware
law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably
believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable
cause to believe such person’s conduct was unlawful.
|
|
|
•
|
The registrant may, in its discretion, indemnify employees and agents as set forth in the General
Corporation Law of the State of Delaware.
|
|
|
•
|
The registrant is required to advance expenses, as incurred, to its directors and officers in connection
with defending a proceeding, except that such director or officer shall undertake to repay such advances if it is ultimately determined
that such person is not entitled to indemnification.
|
|
|
•
|
The registrant will not be obligated pursuant to its amended and restated bylaws to indemnify a
person with respect to proceedings initiated by that person, except with respect to proceedings authorized by the registrant’s
Board of Directors or brought to enforce a right to indemnification.
|
|
|
•
|
The rights conferred in the amended and restated bylaws are not exclusive, and the registrant is
authorized to enter into indemnification agreements with its directors, officers, employees and agents and to obtain insurance
to indemnify such persons.
|
The registrant has entered, and intends
to continue to enter, into separate indemnification agreements with each of its directors and officers that provide the maximum
indemnity allowed to directors and officers by Section 145 of the General Corporation Law of the State of Delaware and also provide
for certain additional procedural protections. The registrant also maintains directors and officers insurance to insure such persons
against certain liabilities.
The indemnification provisions in the registrant’s
amended and restated certificate of incorporation, amended and restated bylaws and the indemnification agreements entered into
between the registrant and its officers and directors may be sufficiently broad to permit indemnification of the registrant’s
officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act.
Item 16. Exhibits
The exhibits to the
registration statement are listed in the Exhibit Index attached hereto and incorporated by reference herein.
Item 17. Undertakings
(a) The undersigned registrant hereby undertakes:
|
|
1.
|
To file, during any period in which offers or sales are being made, a post-effective amendment
to this registration statement:
|
|
|
i.
|
To include any prospectus required by Section 10(a)(3) of the Securities Act;
|
|
|
ii.
|
To reflect in the prospectus any facts or events arising after the effective date of the registration
statement
|
(or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the
registration statement. Notwithstanding the foregoing, any increase or decrease in the volume of common stock offered (if the total
dollar value of common stock offered would not exceed that which was registered) and any deviation from the low or high end of
the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission,
or the SEC, pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in
the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration
statement; and
|
|
iii.
|
To include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement;
|
provided
,
however
, that paragraphs
(1)(i), (1)(ii) and (1)(iii) above do not apply if the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or
Section 15(d) of the Securities Exchange Act of 1934, or the Exchange Act, that are incorporated by reference in the registration
statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
|
|
2.
|
That, for the purpose of determining any liability under the Securities Act of 1933, each such
post-effective amendment shall be deemed to be a new registration statement relating to the common stock offered therein, and the
offering of such common stock at that time shall be deemed to be the initial bona fide offering thereof
|
|
|
3.
|
To remove from registration by means of a post-effective amendment any of the common stock being
registered which remain unsold at the termination of the offering.
|
|
|
4.
|
That, for the purpose of determining liability under the Securities Act to any purchaser:
|
|
|
a.
|
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of
the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
|
|
|
b.
|
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a
registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for
the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and
included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness
or the date of the first contract of sale of common stock in the offering described in the prospectus. As provided in Rule 430B,
for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new
effective date of the registration statement relating to the common stock in the registration statement to which that prospectus
relates, and the offering of such common stock at that time shall be deemed to be the initial bona fide offering thereof. Provided,
however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in
a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration
statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement
that was made in the registration statement or prospectus that was part of the registration statement or made in any such document
immediately prior to such effective date.
|
(b) The undersigned
registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s
annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit
plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the common stock offered therein, and the offering of
the common stock at that time shall be deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification
for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the
registrant pursuant to our amended and restated certificate of incorporation or bylaws, or otherwise, the registrant has been advised
that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other
than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection
with the common stock being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against
public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities
Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Wichita, State of Kansas, on this 16th day of April, 2019.
|
|
CURO GROUP HOLDINGS CORP.
|
|
|
|
|
|
|
By:
|
/s/ Don Gayhardt
|
|
|
Name:
|
Don Gayhardt
|
|
|
Title:
|
President and Chief Executive Officer
|
Pursuant to the requirements of the Securities Act of 1933,
this registration statement has been signed by the following persons in the capacities and on the dates indicated.
|
/s/ Don Gayhardt
|
|
|
Don Gayhardt
|
|
|
President, Chief Executive Officer and a Director
|
|
|
(Principal Executive Officer)
|
|
|
April 16, 2019
|
|
|
|
|
|
/s/ Roger Dean
|
|
|
Roger Dean
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
(Principal Financial Officer)
|
|
|
April 16, 2019
|
|
|
|
|
|
/s/ David Strano
|
|
|
David Strano
|
|
|
Vice President and Chief Accounting Officer
|
|
|
(Principal Accounting Officer)
|
|
|
April 16, 2019
|
|
|
|
|
|
/s/ Doug Rippel
|
|
|
Doug Rippel
|
|
|
Executive Chairman of the Board and a Directors
|
|
|
April 16, 2019
|
|
|
|
|
|
/s/ Chad Faulkner
|
|
|
Chad Faulkner
|
|
|
Director
|
|
|
April 16, 2019
|
|
|
|
|
|
/s/ Andrew Frawley
|
|
|
Andrew Frawley
|
|
|
Director
|
|
|
April 16, 2019
|
|
|
|
|
|
/s/ David Kirchheimer
|
|
|
David Kirchheimer
|
|
|
Director
|
|
|
April 16, 2019
|
|
|
|
|
|
/s/ Chris Masto
|
|
|
Chris Masto
|
|
|
Director
|
|
|
April 16, 2019
|
|
|
|
|
|
/s/ Mike McKnight
|
|
|
Mike McKnight
|
|
|
Director
|
|
|
April 16, 2019
|
|
|
/s/ Dale E. Williams
|
|
|
Dale E. Williams
|
|
|
Director
|
|
|
April 16, 2019
|
|
|
|
|
|
/s/ Karen Winterhof
|
|
|
Karen Winterhof
|
|
|
Director
|
|
|
April 16, 2019
|
|
EXHIBIT INDEX
Exhibit
Number
|
|
Description
|
|
1.1
|
|
Form of Underwriting Agreement *
|
|
3.1
|
|
Amended and Restated Certificate of Incorporation (previously filed as Exhibit 3.1 to the Form 8-K filed on December 11, 2017)
|
|
3.2
|
|
Amended and Restated Bylaws (previously filed as Exhibit 3.2 to the Form 8-K filed on December 11, 2017)
|
|
4.1
|
|
Form of common stock certificate (previously filed as Exhibit 4.1 to Form S-1 filed on November 28, 2017)
|
|
4.2
|
|
Amended and Restated Investors Rights Agreement between the Registrant and the investors listed on the signature pages thereto (previously filed as Exhibit 4.2 to Form S-1 filed on November 28, 2017)
|
|
4.3
|
|
Amendment to Amended and Restated Investors Rights Agreement, dated May 14, 2018, between the Registrant and the investors listed on the signature pages thereto (previously filed as Exhibit 4.3 to Form S-1 filed on May 14, 2018)
|
|
4.4
|
|
Second Amendment to Amended and Restated Investors Rights Agreement, April 16, 2019, between the Registrant and the investors listed on the signature pages thereto
|
|
5.1
|
|
Opinion of Willkie Farr & Gallagher LLP
|
|
23.1
|
|
Consent of Independent Registered Public Accounting Firm
|
|
23.2
|
|
Consent of Willkie Farr & Gallagher LLP (included in Exhibit 5.1)
|
|
24.1
|
|
Power of Attorney
|
|
*
|
|
To be filed by amendment or as an exhibit to a Current Report on Form 8-K and incorporated herein by reference.
|
CURO (NYSE:CURO)
Historical Stock Chart
From Mar 2024 to Apr 2024
CURO (NYSE:CURO)
Historical Stock Chart
From Apr 2023 to Apr 2024
